Skip to content

Effect of a Novel Endoscopic Irrigation Solution on the Quality of Colonoscopy

Effect of a Novel Endoscopic Irrigation Solution on the Quality of Colonoscopy: A Study on Efficacy and Safety

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121268
Enrollment
Unknown
Registered
2026-03-27
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic spasm and colorectal polyps

Interventions

Experimental group:Endoscopic irrigation with a novel endoscopic irrigation solution (0.1% menthol solution combined with dimethyl silicone oil suspension)
Control group:Endoscopic irrigation with normal saline

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Ages 18–75 years, both sexes/gender not limited; 2.Planned for colonoscopy (for screening, diagnostic, or follow-up purposes); 3.Adequate bowel preparation quality (Boston Bowel Preparation Scale score >= 6); 4.Voluntarily signed informed consent and is able to cooperate in completing study-related assessments.

Exclusion criteria

Exclusion criteria: 1.Allergic to menthol, cyclodextrin, or related substances; 2.History of severe intestinal diseases (such as ulcerative colitis, Crohn’s disease, intestinal perforation, intestinal obstruction, intestinal tumors, etc.); 3.With combined severe dysfunction of major organs such as the heart, liver, kidneys, or lungs, or coagulation disorders; 4.Pregnant or lactating women; 5.Those who have used anticholinergic drugs, calcium channel blockers, or other antispasmodic medications within one week prior to the examination; 6.Individuals with mental illness or cognitive impairment that prevents them from cooperating with the study; 7.Those with a history of contraindications to colonoscopy or serious adverse reactions.

Design outcomes

Primary

MeasureTime frame
Adenoma detection rate;

Secondary

MeasureTime frame
Spasm inhibition rate;Incidence of intestinal spasm;Polyp Detection Rate;Cecal intubation time, withdrawal time;Intravenous Antispasmodic Drug Usage Rate;

Countries

China

Contacts

Public ContactJianning Yao

The First Affiliated Hospital of Zhengzhou University

Jianningyao@163.com+86 371 66271117

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026